-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 9, 2018. Such persons may also file a written request for a hearing on the application on or before May 9, 2018.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March 1, 2018, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD, 20852 applied to be registered as an importer of the following basic classes of controlled substances:
Controlled substance Drug code Schedule Cathinone 1235 I Methaqualone 2565 I Lysergic acid diethylamide 7315 I 4-Methyl-2,5-dimethoxyamphetamine 7395 I 4-Methoxyamphetamine 7411 I Codeine-N-oxide 9053 I Difenoxin 9168 I Heroin 9200 I Morphine-N-oxide 9307 I Norlevorphanol 9634 I Methamphetamine 1105 II Phenmetrazine 1631 II Methylphenidate 1724 II Amobarbital 2125 II Pentobarbital 2270 II Secobarbital 2315 II Glutethimide 2550 II Phencyclidine 7471 II Phenylacetone 8501 II Alphaprodine 9010 II Anileridine 9020 II Cocaine 9041 II Start Printed Page 15176 Dihydrocodeine 9120 II Diphenoxylate 9170 II Levomethorphan 9210 II Levorphanol 9220 II Meperidine 9230 II Dextropropoxyphene, bulk (non-dosage forms) 9273 II Thebaine 9333 II Noroxymorphone 9668 II Alfentanil 9737 II Sufentanil 9740 II The company plans to import the bulk controlled substances for distribution of analytical reference standards to its customers for research and analytical purposes.
Start SignatureDated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07167 Filed 4-6-18; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/09/2018
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2018-07167
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 9, 2018. Such persons may also file a written request for a hearing on the application on or before May 9, 2018.
- Pages:
- 15175-15176 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2018-07167.pdf